Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC
West China Hospital
West China Hospital
University of Alabama at Birmingham
Case Comprehensive Cancer Center
Replimune Inc.
Eastern Cooperative Oncology Group
Saint Petersburg State University, Russia
Northwell Health
Vanderbilt University Medical Center
Incyte Corporation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Providence Health & Services
Wake Forest University Health Sciences
University of Miami
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Icahn School of Medicine at Mount Sinai
Actuate Therapeutics Inc.
Adaptimmune
BioMimetix JV, LLC
Asan Medical Center
The University of Hong Kong
Institut Claudius Regaud
University Health Network, Toronto
Odense University Hospital
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
M.D. Anderson Cancer Center
Beijing Konruns Pharmaceutical Co., Ltd.
Johns Hopkins University
Institut de Cancérologie de la Loire
University of California, San Diego
University of Texas Southwestern Medical Center
University of Chicago
Milton S. Hershey Medical Center
University of Chicago
AHS Cancer Control Alberta
University of California, Irvine
University of Michigan Rogel Cancer Center
University of Arkansas
The University of Texas Health Science Center at San Antonio
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
SWOG Cancer Research Network
Radiation Therapy Oncology Group
University of Michigan Rogel Cancer Center
University of Pittsburgh
SWOG Cancer Research Network
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
AstraZeneca